Jobs / United States / Glaxosmithkline LLC
Director, Oncology Translational Medicine Project Manager
Glaxosmithkline LLC · 🇺🇸 5 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles1 certified filing for “Sr Manager - Oncology Commercial Analytics, Multiple Myeloma” (Data Scientists) in PA: $135k–$135k, median $135k. Most were filed at wage level III (100%) — 3 lottery entries, ≈46% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting-edge technology to transform people’s lives. GSK fosters a culture ambitious for patients, accountable for impact, and committed to doing the right thing, making sure that we focus our efforts on accelerating significant assets that meet patients’ needs and have the highest probability of success. We’re uniting science, technology, and talent to get ahead of disease together. Find out more: Our approach to R&D For candidates seeking to be located at our Stevenage site, this role will temporarily be based at Stevenage. However, the Company plans to relocate its offices to Cambridge, UK. The location of this role will therefore subsequently change to Cambridge, UK in accordance with timelines to be set by the Company. The relocation is currently proposed to take effect by early 2029. Director, Oncology Translational Medicine Project Manager Job Purpose: The Oncology Translational Medicine (OTM) Planning & Execution team is a dedicated group of Scientific Operations, Project Management, and Alliance Management professionals that integrate, manage, and drive execution of OTM’s biomarker and diagnostic strategies across GSK’s global Oncology portfolio. The Director, Oncology Translational Medicine Project Manager, will provide high-quality project management support to the delivery of OTM strategic initiatives, and to the OTM Leadership Team, including the Clinical & Translational Biomarkers, Precision Diagnostics, and Clinical Pharmacology Modelling and Simulation (CPMS) divisions. Accountabilities include, but are not limited to, management and oversight of translational research alliances and collaborations, regulatory submission planning and tracking, and coordination of diagnostic target profiles. The OTM Project Manager oversees strategic and operational management of external alliances (e.g. academic centres) for biomarker discovery and acceleration. The OTM Project Manager drives the planning and tracking of portfolio-level CPMS-related regulatory submissions, ensuring high-quality data packages and documentation are delivered to support oncology asset development and approvals. This role also coordinates activities related to target diagnostic profiles. The Director is accountable for planning, execution and stakeholder coordination across OTM and the Oncology Research Unit, Clinical Operations, Data Management, Regulatory, and Finance, as well as external collaborators. The Director will schedule and run project meetings, maintain dashboards and decision logs, oversee budgets, contracts, and resource needs, manage risks and interdependencies, support regulatory submissions and compliance requirements, and deliver clear reporting to the OTM LT. Responsibilities: • Lead operational oversight of external alliances and academic collaborations focused on biomarker discovery and acceleration • Support scientific and business leads in establishing alliance objectives, scope, and success metrics aligned with OTM and Oncology portfolio priorities • Coordinate meeting forums with partners (joint project team, working groups), ensuring decisions, actions, and risks are clearly documented and followed through • Translate the collaboration strategy and vision into integrated, detailed project plans (scope, milestones, critical paths, dependencies, risks) • Track alliance workplans for biomarker discovery, assay development, etc., ensuring partner deliverables align with internal scientific needs and timelines • Monitor performance against agreed mile